News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ulthera Release: Ultherapy® Clinical Studies To Be Presented At AACS 2014 Annual Scientific Meeting Symposia


1/15/2014 8:42:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FT. LAUDERDALE, FL--(Marketwired - January 14, 2014) -

Ulthera, Inc. announced today that its platform ultrasound technology, the Ulthera® System, will be featured in three symposia at the American Academy of Cosmetic Surgery (AACS) 30th Annual Scientific Meeting, Jan. 14-19, 2014 in Hollywood, Fla. at The Westin Diplomat Resort & Spa. Ulthera, Inc. is a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications.

Data from clinical studies evaluating Ultherapy, the non-invasive treatment in which the Ulthera System is used, will be discussed in the following sessions:

Symposium: Applications of Lasers, Fillers, and Toxins
Date/Time: Wednesday, Jan. 15th, 4:00 - 5:30pm ET
Location: Room 314
Data to be Presented: [Pilot Study] Evaluation of the Safety and Effectiveness of Micro-focused Ultrasound with Visualization (MFU-V) for the Treatment of Erythematotelangiectatic Rosacea.
Faculty Presenter: Mark Lupin, MD

Symposium: Choosing/Using Technologies: Clinical Outcomes
Date/Time: Thursday, Jan. 16th, 2:00 - 3:30pm ET
Location: Grand Ballroom West
Data to be Presented: Prospective, Multi-Center, Pivotal Trial Evaluating the Safety and Effectiveness of Micro-focused Ultrasound with Visualization (MFU-V) for Improvement in Lines and Wrinkles of the Décolleté.
Faculty Presenter: Sabrina Fabi, MD

Symposium: Facial Anti-aging
Date/Time: Friday, Jan. 17th, 2:00 - 3:30pm ET
Location: Atlantic 2
Data to be Presented: Evaluation of Micro-focused Ultrasound with Visualization (MFU-V) for Lifting and Tightening of Facial and Neck Skin Laxity Using a Customized, High-Density and Vectoring Treatment Approach.
Faculty Presenter: William Werschler, MD

The Ulthera® System is indicated for use as a non-invasive dermatologic aesthetic treatment to lift the eyebrow and lift lax submental (beneath the chin) and neck tissue.

About Ulthera
Ulthera, Inc. is a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive U.S. FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is an FDA-cleared treatment to lift skin above the brow, on the neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company. For more information, visit www.ultherapy.com.


Media Contact:
Lindsey Karberg
Ulthera, Inc.
480.336.1744
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
Ulthera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES